Northwestern Mutual Wealth Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-671
| Closed | -$9.2K | – | 3850 |
|
|
2024
Q4 | $9.2K | Buy |
671
+629
| +1,498% | +$11.6K | ﹤0.01% | 2769 |
|
|
2024
Q3 | $1.15K | Sell |
42
-149
| -78% | -$4.03K | ﹤0.01% | 3219 |
|
|
2024
Q2 | $4.67K | Buy |
191
+149
| +355% | +$3.27K | ﹤0.01% | 2879 |
|
|
2024
Q1 | $895 | Hold |
42
| – | – | ﹤0.01% | 3203 |
|
|
2023
Q4 | $804 | Hold |
42
| – | – | ﹤0.01% | 3211 |
|
|
2023
Q3 | $674 | Buy |
+42
| New | +$799 | ﹤0.01% | 3085 |
|
|
2023
Q1 | – | Sell |
-49
| Closed | -$711 | – | 3513 |
|
|
2022
Q4 | $711 | Buy |
+49
| New | +$913 | ﹤0.01% | 3085 |
|
|
2022
Q2 | – | Sell |
-150
| Closed | -$4K | – | 3368 |
|
|
2022
Q1 | $4K | Buy |
+150
| New | +$3.84K | ﹤0.01% | 2804 |
|
|
2021
Q2 | – | Sell |
-1,000
| Closed | -$30K | – | 3111 |
|
|
2021
Q1 | $30K | Buy |
+1,000
| New | +$28.4K | ﹤0.01% | 1913 |
|
|
2020
Q4 | – | Sell |
-1,163
| Closed | -$15K | – | 2807 |
|
|
2020
Q3 | $15K | Buy |
1,163
+200
| +21% | +$2.53K | ﹤0.01% | 1885 |
|
|
2020
Q2 | $11K | Buy |
963
+611
| +174% | +$8.68K | ﹤0.01% | 1883 |
|
|
2020
Q1 | $5K | Sell |
352
-293
| -45% | -$6.19K | ﹤0.01% | 2073 |
|
|
2019
Q4 | $18K | Buy |
645
+293
| +83% | +$8.06K | ﹤0.01% | 1769 |
|
|
2019
Q3 | $10K | Sell |
352
-45
| -11% | -$1.31K | ﹤0.01% | 1923 |
|
|
2019
Q2 | $11K | Hold |
397
| – | – | ﹤0.01% | 1926 |
|
|
2019
Q1 | $13K | Buy |
397
+21
| +6% | +$639 | ﹤0.01% | 1869 |
|
|
2018
Q4 | $11K | Buy |
376
+24
| +7% | +$863 | ﹤0.01% | 1798 |
|
|
2018
Q3 | $16K | Hold |
352
| – | – | ﹤0.01% | 1756 |
|
|
2018
Q2 | $13K | Hold |
352
| – | – | ﹤0.01% | 1750 |
|
|
2018
Q1 | $10K | Hold |
352
| – | – | ﹤0.01% | 1757 |
|
|
2017
Q4 | $12K | Sell |
352
-146
| -29% | -$4.93K | ﹤0.01% | 1684 |
|
|
2017
Q3 | $18K | Hold |
498
| – | – | ﹤0.01% | 1496 |
|
|
2017
Q2 | $13K | Hold |
498
| – | – | ﹤0.01% | 1519 |
|
|
2017
Q1 | $10K | Sell |
498
-22
| -4% | -$390 | ﹤0.01% | 1546 |
|
|
2016
Q4 | $8K | Buy |
+520
| New | +$9.41K | ﹤0.01% | 1698 |
|
|
2016
Q3 | – | Sell |
-728
| Closed | -$22K | – | 1033 |
|
|
2016
Q2 | $22K | Hold |
728
| – | – | ﹤0.01% | 1143 |
|
|
2016
Q1 | $28K | Sell |
728
-258
| -26% | -$9.72K | ﹤0.01% | 1072 |
|
|
2015
Q4 | $43K | Sell |
986
-51
| -5% | -$2.15K | ﹤0.01% | 820 |
|
|
2015
Q3 | $39K | Buy |
1,037
+7
| +0.7% | +$248 | ﹤0.01% | 760 |
|
|
2015
Q2 | $35K | Sell |
1,030
-58
| -5% | -$1.97K | ﹤0.01% | 751 |
|
|
2015
Q1 | $39K | Buy |
1,088
+28
| +3% | +$1K | ﹤0.01% | 702 |
|
|
2014
Q4 | $36K | Buy |
1,060
+302
| +40% | +$10.7K | ﹤0.01% | 722 |
|
|
2014
Q3 | $29K | Buy |
758
+205
| +37% | +$7.65K | ﹤0.01% | 725 |
|
|
2014
Q2 | $22K | Hold |
553
| – | – | ﹤0.01% | 749 |
|
|
2014
Q1 | $19K | Sell |
553
-128
| -19% | -$3.97K | ﹤0.01% | 767 |
|
|
2013
Q4 | $14K | Sell |
681
-1,804
| -73% | -$45.6K | ﹤0.01% | 855 |
|
|
2013
Q3 | $59K | Hold |
2,485
| – | – | ﹤0.01% | 547 |
|
|
2013
Q2 | $67K | Buy |
+2,485
| New | +$72K | ﹤0.01% | 500 |
|
Other funds holding MYGN
DGI
GCM
Northwestern Mutual Wealth Management's MYGN Position: Q1 2025 in Review
Northwestern Mutual Wealth Management sold out of Myriad Genetics (MYGN) in Q1 2025, closing a stake of 671 shares — an estimated $9.2K sold.
Northwestern Mutual Wealth Management first reported a position in MYGN in Q2 2013 and held it in 38 quarters. The position peaked at $67K in Q2 2013. 228 funds tracked by Wall St. Rank hold MYGN as of Q1 2025.
- Northwestern Mutual Wealth Management reported no remaining Myriad Genetics position as of Q1 2025 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 671 Myriad Genetics shares in Q1 2025, an estimated $9.2K.
- Northwestern Mutual Wealth Management first reported a position in Myriad Genetics in Q2 2013 and held it in 38 quarters.
- Northwestern Mutual Wealth Management's Myriad Genetics position peaked at $67K in Q2 2013.
- 228 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2025.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.